(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PUSINTIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PUSINTIN

ST13

US500000088884223

Class

5

Filing

88884223

Registration

6199280

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

13

Latest update

11/18/2025

Trademark type

Word

Nice classes

5

Filing date

04/23/2020

Registration date

11/17/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/17/2020

Last transaction

11/18/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

Suzhou, Jiangsu, CN

Examiner

ROCCA,ALAINA M

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

TOT BIOPHARM COMPANY LIMITED

Representatives

ZHI DONG HAMRE, SCHUMANN, MUELLER & LARSON, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for use in chemotherapy; Tumor suppressing agents; Anti-cancer preparations; Anti-sarcoma preparations; Pharmaceutical products for the treatment of cancer; Capsules sold empty for pharmaceuticals; Pharmaceutical preparations for the treatment of cancer; chemical preparations for medical purposesdrugs for the treatment of cancer; Chemical preparations for pharmaceutical purposeschemical preparations for the treatment of cancer; Medicinal preparations for human use for the treatment of cancer; Injectable pharmaceuticalsinjectable pharmaceuticals for the treatment of cancer; Biochemical preparations for medical usebiochemical preparations for the treatment of cancer; Gelatin capsules sold empty for pharmaceuticals

Publications

History of USPTO decisions and trademark events.

13 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

11/17/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

11/17/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/01/2020

PUBO

PUBLISHED FOR OPPOSITION

09/01/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/12/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/28/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

07/24/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/24/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

07/24/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/24/2020

DOCK

ASSIGNED TO EXAMINER

07/16/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/04/2020

NWAP

NEW APPLICATION ENTERED

04/27/2020

Continuous trademark protection

Get notified about every new filing that threatens PUSINTIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.